A critical discovery in cancer research is emerging with the use of VHH fragments to reactivate damaged p53. This essential malignant suppressor protein is frequently inactivated in several forms of tumors, leading https://explorebookmarks.com/story21840669/mini-antibodies-reactivate-p53-new-potential-hope-for-malignant-treatment